Mobile Menu

Search Results

Search results for: Data

Alzheimer’s disease genetic research consortium launched in New York

The State University of New York (SUNY) is running the program with $20 million funding from the Empire State Development’s […]

WGS – The future of consumer genomics

With the falling cost of genome sequencing, it comes as no surprise that there is a growing interest in expanding the availability and accessibility of genomics via consumer testing. Now, Nebula Genomics has entered the market by launching a comprehensive at-home test that analyses the whole genome for just $299.

Opinion: morally, is germline genome editing all that different to IVF?

Helen C. O’Neill has explored how the global reaction to the birth of genome-edited twins in 2018 echoed the condemnation […]

WhopperPhage – The huge virus with CRISPR components

Huge viruses with CRISPR-Cas and translational components have been described by researchers at the University of California, Berkeley – providing […]

Snoring insights from the UK Biobank’s latest study

Even on Valentine’s Day the snoring of a sleeping companion, can be a hard habit to excuse. And, while a UK […]

Machine learning identifies epigenetic markers of Schizophrenia

We know from twin studies that Schizophrenia carries a 80% heritability risk, but haven’t yet managed to deduce exact genetic […]

Butler: Analysing genomes in the cloud

Ask Jeeves may be a thing of the past as there’s a new butler in town. Specifically, one to serve […]

Shareable Science: The genetics of coronavirus

In early December, an outbreak of respiratory illness was reported in Wuhan, China. Scientists quickly determined the sickness was caused by a new virus from the coronavirus family. In an attempt to limit the spread of the virus, China has reacted with transportation lockdowns and public health advisories.

“We are starting to appreciate non-coding DNA” – Interview with Dr Sandra Smieszek, Vanda Pharmaceuticals Inc.

FLG: Can you introduce yourself and your work? I’m Sandra Smieszek and I’m the Head of Genetics at Vanda Pharmaceuticals […]

Foundations for AI are “Critical” to our Continued Success – Interview with Dr Paul Agapow, AstraZeneca

FLG: Can you introduce yourself and your work? I am currently a Health Informatics Director at AstraZeneca. I started my […]